Skip to main content
SpringerLink
Log in

Reply to the letter to the editor: a response to Tran and Egilman

  • Correspondence
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

References

  1. IARC (2012) Asbestos (chrysotile, amosite, crocidolite, tremolite, actinolite and anthophyllite), vol 100C. IARC Monographs, Lyon, pp 196–211

    Google Scholar 

  2. Baan R, Grosse Y, Straif K et al (2009) A review of human carcinogens-Part F: chemical agents and related occupations. Lancet Oncol 10:1143–1144

    Article  PubMed  Google Scholar 

  3. Slomovitz B, de Haydu C, Taub M, Coleman RL, Monk BJ (2021) Asbestos and ovarian cancer: examining the historical evidence. Int J Gynecol Cancer 31:122–128

    Article  PubMed  Google Scholar 

  4. O’Brien KM, Tworoger SS, Harris HR et al (2020) Association of powder use in the genital area with risk of ovarian cancer. JAMA 323:49–59

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wentzensen N, O’Brien KM (2021) Talc, body powder, and ovarian cancer: a summary of the epidemiologic evidence. Gynecol Oncol 163:199–208

    Article  CAS  PubMed  Google Scholar 

  6. Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, et al SEER cancer statistics review, 1975–2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.

  7. Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2021. CA Cancer J Clin 72:7–33

    Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by the Women’s Cancer Research Foundation.

Author information

Authors and Affiliations

  1. Women’s Cancer Research Foundation, 699 Diamond Street, Newport Beach, Laguna Beach, CA, 92651, USA

    John P. Micha, Mark A. Rettenmaier & Bram H. Goldstein

  2. Oso Home Care, Inc., Irvine, CA, USA

    Randy D. Bohart

Authors
  1. John P. Micha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark A. Rettenmaier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Randy D. Bohart
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bram H. Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JM: conceptualization, supervision, original draft preparation, final review. MR: content analysis, draft preparation, final manuscript review. RB: reviewed content, participated in draft preparation, final review. BG: study supervision, original draft preparation, final editing, study approval.

Corresponding author

Correspondence to Bram H. Goldstein.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Micha, J.P., Rettenmaier, M.A., Bohart, R.D. et al. Reply to the letter to the editor: a response to Tran and Egilman. Arch Gynecol Obstet 309, 727–728 (2024). https://doi.org/10.1007/s00404-023-07013-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-023-07013-9

Search

Navigation